Medicine guide

Rivaxa 15 mg + 20 mg filmomhulde tabletten

As listed in the register: Rivaxa 15 mg + 20 mg filmomhulde tabletten

15 mg + 20 mg · filmomhulde tablet

  • Prescription only
  • Blood, clotting and anaemia
Made by
Glenmark Arzneimittel GmbH

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBlood, clotting and anaemiaB01AF01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

FranceNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byGlenmark Arzneimittel GmbH
Active substanceRivaroxaban + Rivaroxaban
Used inBlood, clotting and anaemia
Strength15 mg + 20 mg
Formfilmomhulde tablet
ClassificationB01AF01 · Blood, clotting and anaemia
Routeoraal gebruik
Dispensing (as stated by the register)Uitsluitend recept
RVG134680

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.